Download PDF
Skull Base 2005; 15(1): 15-26
DOI: 10.1055/s-2005-868160
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Surgical Management of Moyamoya Syndrome

Edward R. Smith1 , R. Michael Scott1
  • 1Department of Neurosurgery, The Children's Hospital Boston/Harvard Medical School, Boston, Massachusetts
Further Information

Publication History

Publication Date:
14 April 2005 (online)

    Permissions and Reprints

ABSTRACT

Moyamoya syndrome, a vasculopathy characterized by chronic progressive stenosis at the apices of the intracranial internal carotid arteries, is an increasingly recognized entity which is associated with cerebral ischemia. Diagnosis is made on the basis of clinical and radiographic findings, including a characteristic stenosis of the internal carotid arteries in conjunction with abundant collateral vessel development. Adult moyamoya patients often present with hemorrhage, leading to rapid diagnosis. In contrast, children usually present with transient ischemic attacks or strokes, which may prove more difficult to diagnose because of patient's inadequate verbal and other skills, leading to delayed recognition of the underlying moyamoya. The progression of disease can be slow, with rare, intermittent events, or it can be fulminant, with rapid neurologic decline. However, regardless of the course, it is apparent that moyamoya syndrome, both in terms of arteriopathy and clinical symptoms, inevitably progresses in untreated patients.

Surgery is generally recommended for the treatment of patients with recurrent or progressive cerebral ischemic events and associated reduced cerebral perfusion reserve. Many different operative techniques have been described, all with the main goal of preventing further ischemic injury by increasing collateral blood flow to hypoperfused areas of the cortex, using the external carotid circulation as a donor supply. This article discusses the various treatment approaches, with an emphasis on the use of pial synangiosis, a method of indirect revascularization. The use of pial synangiosis is a safe, effective, and durable method of cerebral revascularization in moyamoya syndrome and should be considered as a primary treatment for moyamoya, especially in the pediatric population.

KEYWORDS

Moyamoya - pial synangiosis - ischemia - stroke

REFERENCES

  • 1 Nagaraja D, Verma A, Taly A B, Kumar M V, Jayakumar P N. Cerebrovascular disease in children.  Acta Neurol Scand. 1994;  90 251-255
    PubMedGoogle Scholar
  • 2 Soriano S G, Sethna N F, Scott R M. Anesthetic management of children with moyamoya syndrome.  Anesth Analg. 1993;  77 1066-1070
    PubMedGoogle Scholar
  • 3 K. TKS . Hypoplasia of the bilateral internal carotid arteries.  Brain Nerve. 1957;  9 37-43
    PubMedGoogle Scholar
  • 4 Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease: disease showing abnormal net-like vessels in base of brain.  Arch Neurol. 1969;  20 288-299
    PubMedGoogle Scholar
  • 5 Suzuki J, Kodama N. Moyamoya disease-a review.  Stroke. 1983;  14 104-109
    CrossrefPubMedGoogle Scholar
  • 6 Caldarelli M, Di Rocco C, Gaglini P. Surgical treatment of moyamoya disease in pediatric age.  J Neurosurg Sci. 2001;  45 83-91
    PubMedGoogle Scholar
  • 7 Yonekawa Y, Ogata N, Kaku Y, Taub E, Imhof H G. Moyamoya disease in Europe, past and present status.  Clin Neurol Neurosurg. 1997;  99 S58-S60
    PubMedGoogle Scholar
  • 8 Han D H, Kwon O K, Byun B J et al.. A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease.  Acta Neurochir (Wien). 2000;  142 1263-1273
    CrossrefPubMedGoogle Scholar
  • 9 Yilmaz E Y, Pritz M B, Bruno A, Lopez-Yunez A, Biller J. Moyamoya: Indiana University Medical Center experience.  Arch Neurol. 2001;  58 1274-1278
    CrossrefPubMedGoogle Scholar
  • 10 Nishimoto UK A, Onbe H. Cooperative study on moyamoya disease in Japan. Cooperative study on moyamoya disease in Japan. 1981: 53-58
    Google Scholar
  • 10a Scott R M, Smith J L, Robertson R L, Madsen J R, Soriano S G, Rockoff M A. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.  J Neurosurg Spine. 2004;  100 142-149
    PubMedGoogle Scholar
  • 11 Nakakita K, Tanaka S, Fukuda A, Fujii C, Kohama A, Miyasato H. Nontraumatic acute subdural hematoma caused by the rupture of transdural anastomotic vessels in moyamoya disease [in Japanese].  No Shinkei Geka. 1994;  22 561-565
    PubMedGoogle Scholar
  • 12 Ohaegbulam C, Scott R M. Moyamoya syndrome. In: McLone D Pediatric Neurosurgery Philadelphia, PA; WB Saunders 2001: 1077-1092
    Google Scholar
  • 13 Hoshimaru M, Takahashi J A, Kikuchi H, Nagata I, Hatanaka M. Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study.  J Neurosurg. 1991;  75 267-270
    PubMedGoogle Scholar
  • 14 Takahashi A, Sawamura Y, Houkin K, Kamiyama H, Abe H. The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor.  Neurosci Lett. 1993;  160 214-216
    CrossrefPubMedGoogle Scholar
  • 15 Suzui H, Hoshimaru M, Takahashi J A et al.. Immunohistochemical reactions for fibroblast growth factor receptor in arteries of patients with moyamoya disease.  Neurosurgery. 1994;  35 20-24 , discussion 24-25
    PubMedGoogle Scholar
  • 16 Malek A M, Connors S, Robertson R L, Folkman J, Scott R M. Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders.  Pediatr Neurosurg. 1997;  27 182-189
    PubMedGoogle Scholar
  • 17 Soriano S G, Cowan D B, Proctor M R, Scott R M. Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya syndrome.  Neurosurgery. 2002;  50 544-549
    PubMedGoogle Scholar
  • 18 Ikeda E. Systemic vascular changes in spontaneous occlusion of the circle of Willis.  Stroke. 1991;  22 1358-1362
    PubMedGoogle Scholar
  • 19 Gordon N, Isler W. Childhood moyamoya disease.  Dev Med Child Neurol. 1989;  31 103-107
    PubMedGoogle Scholar
  • 20 Kitahara T, Ariga N, Yamaura A, Makino H, Maki Y. Familial occurrence of moya-moya disease: report of three Japanese families.  J Neurol Neurosurg Psychiatry. 1979;  42 208-214
    PubMedGoogle Scholar
  • 21 Sogaard I, Jorgensen J. Familial occurrence of bilateral intracranial occlusion of the internal carotid arteries (Moya Moya).  Acta Neurochir (Wien). 1975;  31 245-252
    CrossrefPubMedGoogle Scholar
  • 22 Yamauchi T, Tada M, Houkin K et al.. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25.  Stroke. 2000;  31 930-935
    CrossrefPubMedGoogle Scholar
  • 23 Inoue T K, Ikezaki K, Sasazuki T, Matsushima T, Fukui M. Linkage analysis of moyamoya disease on chromosome 6.  J Child Neurol. 2000;  15 179-182
    CrossrefPubMedGoogle Scholar
  • 24 Kestle J R, Hoffman H J, Mock A R. Moyamoya phenomenon after radiation for optic glioma.  J Neurosurg. 1993;  79 32-35
    CrossrefPubMedGoogle Scholar
  • 25 Okuno T, Prensky A L, Gado M. The moyamoya syndrome associated with irradiation of an optic glioma in children: report of two cases and review of the literature.  Pediatr Neurol. 1985;  1 311-316
    CrossrefPubMedGoogle Scholar
  • 26 Bitzer M, Topka H. Progressive cerebral occlusive disease after radiation therapy.  Stroke. 1995;  26 131-136
    PubMedGoogle Scholar
  • 27 Maki Y, Enomoto T. Moyamoya disease.  Childs Nerv Syst. 1988;  4 204-212
    CrossrefPubMedGoogle Scholar
  • 28 Fukuyama Y, Umezu R. Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of Willis (“moyamoya” disease) in children.  Brain Dev. 1985;  7 21-37
    PubMedGoogle Scholar
  • 29 Imaizumi T, Hayashi K, Saito K, Osawa M, Fukuyama Y. Long-term outcomes of pediatric moyamoya disease monitored to adulthood.  Pediatr Neurol. 1998;  18 321-325
    CrossrefPubMedGoogle Scholar
  • 30 Chabbert V, Ranjeva J P, Sevely A, Boetto S, Berry I, Manelfe C. Diffusion- and magnetisation transfer-weighted MRI in childhood moya-moya.  Neuroradiology. 1998;  40 267-271
    CrossrefPubMedGoogle Scholar
  • 31 Yamada I, Suzuki S, Matsushima Y. Moyamoya disease: comparison of assessment with MR angiography and MR imaging versus conventional angiography.  Radiology. 1995;  196 211-218
    PubMedGoogle Scholar
  • 32 Yamada I, Matsushima Y, Suzuki S. Childhood moyamoya disease before and after encephalo-duro-arterio-synangiosis: an angiographic study.  Neuroradiology. 1992;  34 318-322
    CrossrefPubMedGoogle Scholar
  • 33 Yamada I, Matsushima Y, Suzuki S. Moyamoya disease: diagnosis with three-dimensional time-of-flight MR angiography.  Radiology. 1992;  184 773-778
    PubMedGoogle Scholar
  • 34 Yamada I, Suzuki S, Matsushima Y. Moyamoya disease: diagnostic accuracy of MRI.  Neuroradiology. 1995;  37 356-361
    PubMedGoogle Scholar
  • 35 Katz D A, Marks M P, Napel S A, Bracci P M, Roberts S L. Circle of Willis: evaluation with spiral CT angiography, MR angiography, and conventional angiography.  Radiology. 1995;  195 445-449
    PubMedGoogle Scholar
  • 36 Takanashi J I, Sugita K, Niimi H. Evaluation of magnetic resonance angiography with selective maximum intensity projection in patients with childhood moyamoya disease.  Eur J Paediatr Neurol. 1998;  2 83-89
    CrossrefPubMedGoogle Scholar
  • 37 Chang K H, Yi J G, Han M H, Kim I O. MR imaging findings of moyamoya disease.  J Korean Med Sci. 1990;  5 85-90
    PubMedGoogle Scholar
  • 38 Kodama N, Aoki Y, Hiraga H, Wada T, Suzuki J. Electroencephalographic findings in children with moyamoya disease.  Arch Neurol. 1979;  36 16-19
    PubMedGoogle Scholar
  • 39 Takase K, Kashihara M, Hashimoto T. Transcranial Doppler ultrasonography in patients with moyamoya disease.  Clin Neurol Neurosurg. 1997;  99 S101-S105
    PubMedGoogle Scholar
  • 40 Morgenstern C, Griewing B, Muller-Esch G, Zeller J A, Kessler C. Transcranial power-mode duplex ultrasound in two patients with moyamoya syndrome.  J Neuroimaging. 1997;  7 190-192
    PubMedGoogle Scholar
  • 41 Takeuchi S, Tanaka R, Ishii R, Tsuchida T, Kobayashi K, Arai H. Cerebral hemodynamics in patients with moyamoya disease. A study of regional cerebral blood flow by the 133Xe inhalation method.  Surg Neurol. 1985;  23 468-474
    PubMedGoogle Scholar
  • 42 Nambu K, Suzuki R, Hirakawa K. Cerebral blood flow: measurement with xenon-enhanced dynamic helical CT.  Radiology. 1995;  195 53-57
    PubMedGoogle Scholar
  • 43 Liu H M, Peng S S, Li Y W. The preoperative and postoperative cerebral blood flow and vasoreactivity in childhood moyamoya disease.  Keio J Med. 2000;  49 A86-A89
    PubMedGoogle Scholar
  • 44 Shirane R, Yoshida Y, Takahashi T, Yoshimoto T. Assessment of encephalo-galeo-myo-synangiosis with dural pedicle insertion in childhood moyamoya disease: characteristics of cerebral blood flow and oxygen metabolism.  Clin Neurol Neurosurg. 1997;  99 S79-S85
    PubMedGoogle Scholar
  • 45 Scott R M. Moyamoya syndrome: a surgically treatable cause of stroke in the pediatric patient.  Clin Neurosurg. 2000;  47 378-384
    PubMedGoogle Scholar
  • 46 Scott R M. Surgery for moyamoya syndrome? Yes.  Arch Neurol. 2001;  58 128-129
    CrossrefPubMedGoogle Scholar
  • 47 Matsushima T, Inoue T, Katsuta T et al.. An indirect revascularization method in the surgical treatment of moyamoya disease-various kinds of indirect procedures and a multiple combined indirect procedure.  Neurol Med Chir (Tokyo). 1998;  38 297-302
    PubMedGoogle Scholar
  • 48 Kawaguchi S, Okuno S, Sakaki T. Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease.  J Neurosurg. 2000;  93 397-401
    PubMedGoogle Scholar
  • 49 Houkin K, Kamiyama H, Abe H, Takahashi A, Kuroda S. Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage?.  Stroke. 1996;  27 1342-1346
    PubMedGoogle Scholar
  • 50 Sencer S, Poyanli A, Kiris T, Sencer A, Minareci O. Recent experience with Moyamoya disease in Turkey.  Eur Radiol. 2000;  10 569-572
    CrossrefPubMedGoogle Scholar
  • 51 Houkin K, Kuroda S, Nakayama N. Cerebral revascularization for moyamoya disease in children.  Neurosurg Clin N Am. 2001;  12 575-584 , ix
    PubMedGoogle Scholar
  • 52 Dauser R C, Tuite G F, McCluggage C W. Dural inversion procedure for moyamoya disease [technical note].  J Neurosurg. 1997;  86 719-723
    PubMedGoogle Scholar
  • 53 Sato H, Ogawa A, Takahashi A et al.. Influence of superior cervical ganglion on cerebral hemodynamics-measurements of cerebral blood flow and metabolism during superior cervical ganglionectomy in patients with moyamoya disease [in Japanese].  No To Shinkei. 1990;  42 203-208
    PubMedGoogle Scholar
  • 54 Ohtaki M, Uede T, Morimoto S, Nonaka T, Tanabe S, Hashi K. Intellectual functions and regional cerebral haemodynamics after extensive omental transplantation spread over both frontal lobes in childhood moyamoya disease.  Acta Neurochir (Wien). 1998;  140 1043-1053
    CrossrefPubMedGoogle Scholar
  • 55 Matsushima T, Inoue T, Ikezaki K et al.. Multiple combined indirect procedure for the surgical treatment of children with moyamoya disease. A comparison with single indirect anastomosis with direct anastomosis.  Neurosurgical Focus. 1998;  5 , Article 4
    PubMedGoogle Scholar
  • 56 Matsushima Y. Indirect anastomoses for moyamoya disease [in Japanese].  No Shinkei Geka. 1998;  26 769-786
    PubMedGoogle Scholar
  • 57 Yoshioka N, Tominaga S, Inui T. Cerebral revascularization using omentum and serratus anterior muscle free flap transfer for adult moyamoya disease: case report.  Surg Neurol. 1996;  46 430-435 , discussion 435-436
    CrossrefPubMedGoogle Scholar
  • 58 Yoshioka N, Tominaga S, Suzuki Y et al.. Cerebral revascularization using omentum and muscle free flap for ischemic cerebrovascular disease.  Surg Neurol. 1998;  49 58-65 , discussion 65-56
    CrossrefPubMedGoogle Scholar
  • 59 Touho H, Karasawa J, Tenjin H, Ueda S. Omental transplantation using a superficial temporal artery previously used for encephaloduroarteriosynangiosis.  Surg Neurol. 1996;  45 550-558 , discussion 558-559
    PubMedGoogle Scholar
  • 60 Karasawa J, Kikuchi H, Kawamura J, Sakai T. Intracranial transplantation of the omentum for cerebrovascular moyamoya disease: a two-year follow-up study.  Surg Neurol. 1980;  14 444-449
    PubMedGoogle Scholar
  • 61 Karasawa J, Touho H, Ohnishi H, Miyamoto S, Kikuchi H. Cerebral revascularization using omental transplantation for childhood moyamoya disease.  J Neurosurg. 1993;  79 192-196
    PubMedGoogle Scholar
  • 62 Havlik R J, Fried I, Chyatte D, Modlin I M. Encephalo-omental synangiosis in the management of moyamoya disease.  Surgery. 1992;  111 156-162
    PubMedGoogle Scholar
  • 63 Suzuki J, Takaku A, Kodama N, Sato S. An attempt to treat cerebrovascular “Moyamoya” disease in children.  Childs Brain. 1975;  1 193-206
    PubMedGoogle Scholar
  • 64 Mizoi K, Kayama T, Yoshimoto T, Nagamine Y. Indirect revascularization for moyamoya disease: is there a beneficial effect for adult patients?.  Surg Neurol. 1996;  45 541-548 , discussion 548-549
    PubMedGoogle Scholar
  • 65 Kashiwagi S, Kato S, Yasuhara S, Wakuta Y, Yamashita T, Ito H. Use of a split dura for revascularization of ischemic hemispheres in moyamoya disease.  J Neurosurg. 1996;  85 380-383
    PubMedGoogle Scholar
  • 66 Takemura S, Sato S, Kuroki A, Saito S, Kayama T. New ideas for indirect revascularization surgery for moyamoya disease [in Japanese].  No Shinkei Geka. 1999;  27 987-992
    PubMedGoogle Scholar
  • 67 Ikezaki K. Rational approach to treatment of moyamoya disease in childhood.  J Child Neurol. 2000;  15 350-356
    PubMedGoogle Scholar
  • 68 Nomura S, Kashiwagi S, Uetsuka S, Uchida T, Kubota H, Ito H. Perioperative management protocols for children with moyamoya disease.  Childs Nerv Syst. 2001;  17 270-274
    CrossrefPubMedGoogle Scholar
  • 69 Lin Y, Yoshiko K, Negoro T, Watanabe K, Negoro M. Cerebral oxygenation state in childhood moyamoya disease: a near-infrared spectroscopy study.  Pediatr Neurol. 2000;  22 365-369
    CrossrefPubMedGoogle Scholar
  • 70 Fujiwara J, Nakahara S, Enomoto T, Nakata Y, Takita H. The effectiveness of O2 administration for transient ischemic attacks in moyamoya disease in children.  Childs Nerv Syst. 1996;  12 69-75
    CrossrefPubMedGoogle Scholar

Edward R SmithM.D. 

Department of Neurosurgery, The Children's Hospital Boston/Harvard Medical School

300 Longwood Ave., Boston, MA 02115

Email: edward.smith@childrens.harvard.edu